This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

ChinaBio® Partnering Forum
The Kerry Hotel
September 10–11, 2024 | Shanghai, ChinaSeptember 16–17, 2024 | Virtual

Ben Ni
CBO at GenSci


Dr. Binhui Ni, Vice President, Chief Business Officer and Chief Strategy Officer of Changchun GeneScience Pharmaceutical Co.,Ltd.

Dr. Ni has rich experience in R&D, cross-border investment and business development. Dr. Ni has successively held senior scientific research and management positions in the world's top 500 enterprises for more than 25 years, including Lilly, general manager of Covens Greater China, R&D director of GSK and vice president of Sanofi. He has published articles in more than 40 international famous journals such as "Science" and "PNAS", and served as visiting professors in Universities in the United States and Singapore. While working in Sanofi, Dr. Ni took the lead in preparing for the establishment of a global R&D strategy and foreign cooperation team in China, and successfully developed Sanofi's business to cover the whole Asia Pacific region including Japan. He is responsible for implementing the foreign cooperation business strategy of multinational giants in Asia and China, including drug R&D, technology transfer, licensing and business development, and has made remarkable achievements. In terms of investment, Dr. Ni used to be the managing partner of Yoo India pharmaceutical fund and has also founded two biotechnology companies.

Agenda Sessions

  • Clinical development, commercialization and partnering in China: How China has fundamentally altered the global clinical development landscape